Effectiveness and safety of enfortumab vedotin and pembrolizumab in a real-world patient population with urothelial carcinoma: results from a multi-institutional cohort (GUARDIANS). - Zschäbitz S; Bhatti I; Casuscelli J; Pachmayr LO; Büttner T; Elegeert T; Holzwarth N; Rodler S; Hennig M; Rinderknecht E; Dib M; Schlack K; et al. (Cancer immunology, immunotherapy : CII, 2026)